Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.

Lilenbaum, Rogerio

Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Oct 2006 - 4825-32 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

1527-7755

10.1200/JCO.2006.07.4773 doi


Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Camptothecin--administration & dosage
Carcinoma, Non-Small-Cell Lung--drug therapy
Celecoxib
Cyclooxygenase Inhibitors--therapeutic use
Deoxycytidine--administration & dosage
Docetaxel
Female
Humans
Irinotecan
Lung Neoplasms--drug therapy
Male
Middle Aged
Pyrazoles--therapeutic use
Sulfonamides--therapeutic use
Survival Analysis
Taxoids--administration & dosage
Treatment Outcome
Gemcitabine